Profession Notes

Stamp of Approval Thirty-two researchers at institutions located in 15 states plus Australia and Israel have received grants that were funded through the sale of postage stamps. The National Cancer Institute (NCI) recently awarded the grants under the Insight Awards to Stamp Out Breast Cancer program. A 1997 law set up the program, which allows for contributions to breast cancer research funding to come from the sale of a first-class stamp for 40 cents. The funding is divided between the Nation

Written byMargaret Heinrich
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Thirty-two researchers at institutions located in 15 states plus Australia and Israel have received grants that were funded through the sale of postage stamps. The National Cancer Institute (NCI) recently awarded the grants under the Insight Awards to Stamp Out Breast Cancer program. A 1997 law set up the program, which allows for contributions to breast cancer research funding to come from the sale of a first-class stamp for 40 cents. The funding is divided between the National Institutes of Health (75 percent) and the Department of Defense (25 percent). NCI awarded a total of $6.9 million to the researchers in the form of two-year grants funding up to $75,000 per year in direct costs. A total of 403 researchers competed for the grants based on program specifications calling for studies in areas presently underrepresented--studies with high risk but also with a significant potential for reward. Eight areas of breast ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies